M. Nijhoff

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Michiel F Nijhoff, Michiel . Nijhoff, M F Nijhoff, M. F. Nijhoff, Michiel F. Nijhoff, M Nijhoff, Michiel Nijhoff
Publication record
30 papers · 381 citations · H-index 9

PAPERS

Expert Consensus on the Primary Aldosteronism Severity Classification (EC-PASC) and its Strategic Application in Indicating Adrenal Venous Sampling.
202510 citationsauthor #15
A clinical decision model for failed adrenal vein sampling in primary aldosteronism
20252 citationsauthor #7
Comparison of an oral mixed meal plus arginine and intravenous glucose, GLP-1 plus arginine to unmask residual islet function in longstanding type 1 diabetes
20240 citationsauthor #2
Bone Material Strength index is low in Patients with Cushing's Syndrome even after long-term remission.
20240 citationsauthor #6
Impact of a Public Health Emergency on Behavior, Stress, Anxiety and Glycemic Control in Patients With Pancreas or Islet Transplantation for Type 1 Diabetes
20240 citationsauthor #4
Monitoring beta cell survival after intrahepatic islet transplantation using dynamic exendin PET imaging: a proof-of-concept study in individuals with type 1 diabetes.
20236 citationsauthor #4
International multicenter survey on screening and confirmatory testing in primary aldosteronism.
202323 citationsauthor #31
Chronic Pancreas Allograft Rejection Followed by Successful HLA-Incompatible Islet Alloautotransplantation: A Novel Strategy?
20230 citationsauthor #2
Diagnosis and treatment of allograft rejection in islet transplantation.
20238 citationsauthor #2
201.5: TNF-alpha blockade during islet transplantation in immunosuppressed recipients: a study on in vitro, clinical, and CITR registry-derived data
20231 citationsauthor #3
P.101: Safety and Efficacy of a Percutaneous Intraportal Islet Transplantation Procedure Using Tract Embolization With Gelatine Foam Pledgets.
20210 citationsauthor #1
Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic
2021140 citationsauthor #6
Clinical use of donation after circulatory death pancreas for islet transplantation
202114 citationsauthor #2
Adrenal Vein Sampling in a Patient With Primary Hyperaldosteronism and Severe Contrast Allergy
20216 citationsauthor #5
P.100: Impact of Islet Purity on Short- and Long-term Graft Function in Islet Allotransplantation.
20210 citationsauthor #3
105.4: Impact of the COVID-19 Lockdown on Behavior, Stress, Anxiety and Glycemic Control in Patients With Beta Cell Transplantation.
20210 citationsauthor #4
Bone material strength index is altered in patients with Cushings syndrome even after long-term remission
20211 citationsauthor #4
Psychological Symptoms and Quality of Life After Simultaneous Kidney and Pancreas Transplantation
202011 citationsauthor #1
Fasting parameters for estimation of stimulated β cell function in islet transplant recipients with or without basal insulin treatment
20209 citationsauthor #2
Assessment of intrahepatic islet of Langerhans transplantation with dynamic Ga-68-NODAGA-exendin PET imaging
20192 citationsauthor #6
Islet alloautotransplantation: Allogeneic pancreas transplantation followed by transplant pancreatectomy and islet transplantation
20187 citationsauthor #1
Artificial Pancreas or Novel Beta-Cell Replacement Therapies: a Race for Optimal Glycemic Control?
201816 citationsauthor #1
Diazoxide pretreatment improves pancreatic islet survival in vitro and functionality in vivo
20181 citationsauthor #1
[Transplantation of islets of Langerhans: procedure, indications and challenges].
20181 citationsauthor #1
Glycemic Stability Through Islet‐After‐Kidney Transplantation Using an Alemtuzumab‐Based Induction Regimen and Long‐Term Triple‐Maintenance Immunosuppression
201639 citationsauthor #1
Central serous chorioretinopathy in primary hyperaldosteronism
201629 citationsauthor #2
A novel clinical phenotype of acquired partial lipodystrophy associated with intensive childhood cytostatic treatment
20160 citationsauthor #1
Diagnostic challenges in severe primary hyperaldosteronism
20160 citationsauthor #1
Improved glycemic control and stable renal function following islet-after-kidney transplantation using an alemtuzumab-based induction regime in type 1 diabetes
20140 citationsauthor #1
ACTH-producing pheochromocytoma: clinical considerations and concise review of the literature.
200957 citationsauthor #1

TIMELINE

2009 57 citations

2014 0 citations

2016 68 citations

2018 25 citations

2019 2 citations

2020 20 citations

2021 161 citations

2023 38 citations

2024 0 citations

2025 12 citations

M. Nijhoff

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT